2009•Journal of Asian Natural Products ResearchRequires access

Postantibiotic effect of purified melittin from honeybee (Apis mellifera) venom againstEscherichia coliandStaphylococcus aureus

Sang‐Mi Han, Joo‐Hong Yeo, Ha-Ju Baek, Shin-Min Lin, Stacey J. Meyer, Peter C. Molan

Open publisher page 33 citations

Abstract

Since the ancient times, the antibacterial application of honeybee venom (BV) has been practised and persisted. We investigated the antibacterial activity of whole BV and purified melittin against Escherichia coli and Staphylococcus aureus by the minimum inhibitory concentrations (MICs) and the postantibiotic effects (PAEs). The in vitro PAEs of whole BV and isolated melittin were determined using E. coli and S. aureus. The PAEs of whole BV against E. coli and S. aureus were 0.15 h (1 x MIC), 2.4 h (5 x MIC), and 3.45 h (1 x MIC), respectively. The PAEs of melittin against E. coli and S. aureus were 0.1 h (1 x MIC), 3.2 h (5 x MIC), and 4.35 h (1 x MIC), respectively. These results suggest that whole BV and melittin will be developed as a novel antibacterial drug.

About this research paper

What this paper is about

Since the ancient times, the antibacterial application of honeybee venom (BV) has been practised and persisted. We investigated the antibacterial activity of whole BV and purified melittin against Escherichia coli and Staphylococcus aureus by the minimum inhibitory concentrations (MICs) and the postantibiotic effects (PAEs). The in vitro PAEs of whole BV and isolated melittin were determined using E. coli and S. aureus. The PAEs of whole BV against E. coli and S. aureus were 0.15 h (1 x MIC), 2.4 h (5 x MIC), and 3.45 h (1 x MIC), respectively. The PAEs of melittin against E. coli and S. aureus were 0.1 h (1 x MIC), 3.2 h (5 x MIC), and 4.35 h (1 x MIC), respectively. These results suggest that whole BV and melittin will be developed as a novel antibacterial drug.

Why it matters

OpenAlex reports 33 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Since the ancient times, the antibacterial application of honeybee venom (BV) has been practised and persisted. We investigated the antibacterial activity of whole BV and purified melittin against Escherichia coli and Staphylococcus aureus by the minimum inhibitory concentrations (MICs) and the postantibiotic effects (PAEs). The in vitro PAEs of whole BV and isolated melittin were determined using E. coli and S. aureus. The PAEs of whole BV against E. coli and S. aureus were 0.15 h (1 x MIC), 2.4 h (5 x MIC), and 3.45 h (1 x MIC), respectively. The PAEs of melittin against E. coli and S. aureus were 0.1 h (1 x MIC), 3.2 h (5 x MIC), and 4.35 h (1 x MIC), respectively. These results suggest that whole BV and melittin will be developed as a novel antibacterial drug.

Key concepts: Melittin, Venom, Staphylococcus aureus, Escherichia coli, Microbiology, Biology, Bee venom, Chemistry

Related papers

Back to paper searchBrowse research topicsOriginal source
Postantibiotic effect of purified melittin from honeybee (Apis mellifera) venom againstEscherichia coliandStaphylococcus aureus — Research Paper | ScholarLens